Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Molex introduces 1.25 pitch PicoBlade connector June 8, 2018 Could Barcelona Become the World’s Additive Manufacturing Hub? October 18, 2017 Environment ministry panel eases coal mine expansion rules August 9, 2017